MBX Biosciences, Inc. (MBX)
53.49
+0.39
(+0.73%)
USD |
NASDAQ |
Nov 18, 16:00
54.20
+0.71
(+1.33%)
After-Hours: 20:00
MBX Biosciences Price : 53.49 for Nov. 18, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 17, 2026 | 53.28 | 54.00 | 50.22 | 53.10 | 356069.0 |
| Nov 16, 2026 | 55.45 | 56.95 | 52.90 | 53.12 | 391286.0 |
| Nov 13, 2026 | 54.49 | 57.11 | 52.94 | 55.94 | 855453.0 |
| Nov 12, 2026 | 57.22 | 57.82 | 54.30 | 54.51 | 321987.0 |
| Nov 11, 2026 | 56.33 | 58.56 | 55.25 | 57.72 | 556665.0 |
| Nov 10, 2026 | 51.52 | 58.12 | 51.52 | 56.33 | 1.124M |
| Nov 09, 2026 | 52.57 | 54.86 | 51.96 | 54.06 | 666076.0 |
| Nov 06, 2026 | 49.15 | 52.15 | 48.44 | 51.35 | 488160.0 |
| Nov 05, 2026 | 52.63 | 52.69 | 47.55 | 48.46 | 427887.0 |
| Nov 04, 2026 | 55.95 | 57.00 | 51.73 | 52.48 | 424993.0 |
| Nov 03, 2026 | 55.11 | 57.10 | 54.65 | 55.00 | 287590.0 |
| Nov 02, 2026 | 55.97 | 57.42 | 54.21 | 54.40 | 326395.0 |
| Oct 30, 2026 | 53.72 | 56.57 | 52.28 | 55.87 | 667267.0 |
| Oct 29, 2026 | 54.51 | 56.18 | 53.25 | 54.54 | 257204.0 |
| Oct 28, 2026 | 52.53 | 54.55 | 49.85 | 54.16 | 258000.0 |
| Oct 27, 2026 | 50.24 | 53.63 | 50.05 | 52.97 | 492993.0 |
| Oct 26, 2026 | 48.93 | 50.81 | 47.93 | 50.29 | 653050.0 |
| Oct 23, 2026 | 50.15 | 50.15 | 47.50 | 48.50 | 581557.0 |
| Oct 22, 2026 | 53.50 | 54.99 | 50.25 | 50.46 | 631691.0 |
| Oct 21, 2026 | 53.87 | 56.20 | 53.43 | 53.93 | 400364.0 |
| Oct 20, 2026 | 52.56 | 55.00 | 51.05 | 53.50 | 808029.0 |
| Oct 19, 2026 | 49.70 | 53.06 | 49.70 | 52.48 | 522210.0 |
| Oct 16, 2026 | 50.69 | 50.88 | 49.22 | 49.61 | 818922.0 |
| Oct 15, 2026 | 49.15 | 51.30 | 48.73 | 50.71 | 601768.0 |
| Oct 14, 2026 | 48.02 | 49.54 | 47.60 | 48.82 | 994415.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Ligand Pharmaceuticals, Inc. | 299.00 |
| Xeris Biopharma Holdings, Inc. | 16.99 |
| ANI Pharmaceuticals, Inc. | 69.47 |
| Corcept Therapeutics, Inc. | 67.72 |
| Veru, Inc. | 2.31 |
Price Related Metrics
| PEG Ratio | -0.6281 |
| Price to Book Value | 5.614 |
| Earnings Yield | -5.72% |
| Market Cap | 2.655B |
| PEGY Ratio | -0.6281 |